CClinicalTrials.gg
CompletedNCT06478082Updated Jun 27, 2024

Home-based Virtual Reality Rehabilitation for Children With Cerebral Palsy

An interventional study of Home-based virtual reality training in Cerebral Palsy, sponsored by Sint Maartenskliniek. Completed at 1 site in Netherlands. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-06-27.

Sponsored by Sint Maartenskliniek · Not applicable, Interventional, and Device feasibility

From the registry’s dates

  • Registered 2 years 10 months after the study started (first participant enrolled Apr 2021, registered Mar 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
10 Years to 18 Years
Sex
All
01

Study summary

Rationale: In a way, VR-based gaming shows some similarities to Constraint-induced movement therapy. VR games are controlled unimanually or bimanually. When unimanually-controlled games are performed with the affected upper limb, movements of the unaffected hand are completely ineffective. This mimics the principle of forced use. To some degree, also bimanually-controlled games result in a forced use of the affected upper limb.

Additionally, VR could help in the engagement in rehabilitation programs, as virtual environments and gaming increases enjoyment and motivation, and therefore therapy adherence. Accordingly, VR-based gaming may have the potential to improve upper limb functionality in children with CP.

Objective: This study aims to investigate the feasibility of a home-based VR intervention to improve upper limb functionality in children with CP. Sub-objective: The validation of a self-developed upper limb assessment (Upper Limb Reaching Test).

Study population: Children and adolescents with unilateral CP (age 10-18 years old). Intervention: The intervention consists of VR-based rehabilitation with the Oculus Quest device. The training frequency and duration represents 2x15 minutes a day, five days a week, for a total of eight weeks. Therefore, this rehabilitation intervention should represent a total amount of 20 hours of rehabilitation. However, the total dosage is variable as the intervention is self-managed.

Main study parameters/endpoints: Logbook, System Usability Scale, Melbourne Assessment 2, Wall Arm Reaching Test, Elbow and shoulder range of motion.

02

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • Home-based rehabilitation
  • Virtual Reality
  • Upper limb
03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's enrollment of 13 is below the median of 33 across 1,368 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Sint Maartenskliniek is the lead sponsor of 28 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • CP children with a unilateral or severely asymmetric, bilateral spastic movement impairment.
  • Age 10-18 years old.
  • Manual Ability Classification System (MACS) scores I, II or III.
  • House classification of 1, 2 or 3.

Exclusion criteria

Exclusion Criteria:

  • Significant (persisting) motion sickness, or any other related adverse event in VR.
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    Children with unilateral Cerebral Palsy

    All children have unilateral cerebral palsy and are between 1-18 years old

    Device: Home-based virtual reality training

Interventions

  • DeviceHome-based virtual reality training

    8-week training with an advised frequency of 30 minutes per day, for 5 days per week.

06

What researchers measure

Primary outcomes

  1. Logbook

    Participants keep a logbook in which they log the date of training, games played, duration of activity and enjoyment of game

    Time frame: During the 8-week intervention period

  2. System Usability Scale

    This questionnaire consists of 10 items regarding the usability of the virtual reality training. Scores ranging between 0-100, with a higher score indicating better usability

    Time frame: After the 8-week intervention

Secondary outcomes

  1. Melbourne Assessment 2

    Item 1,2,10 and 13 were measured to evaluate quality of upper limb movements, specifically reaching movements. Scores ranging between 0-33, with a higher score indicating better arm function.

    Time frame: Before and after 8-week intervention

  2. Wall Arm Reaching Test

    A test to evaluate the reaching ability in children with cerebral palsy. Children have to alternate with their arm between the hip and a target on the wall as fast a possible in 30 seconds. Scoring starts at 0 and has no maximum. A higher score, indicates a better arm functioning.

    Time frame: Before and after 8-week intervention

  3. Range of motion Elbow

    Passive and active range of motion of the extension of the elbow. Ranging between 0-180 degrees. Closer to 0 indicating better extension.

    Time frame: Before and after 8-week intervention

  4. Rang om motion Shoulder

    Passive and active range of motion of the anteflexion of the shoulder. Ranging between 0-180 degrees. Closer to 180 indicating better anteflexion.

    Time frame: Before and after 8-week intervention

07

Study locations

1 site
  • Sint Maartenskliniek
    Ubbergen, Gelderland 6574 NA, Netherlands
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06478082
Lead sponsor
Sint Maartenskliniek
Responsible party
Sponsor
First posted
Jun 27, 2024
Start date
Apr 12, 2021
Primary completion
Jul 3, 2023
Completion
Jul 3, 2023
Last update
Jun 27, 2024

Study contacts

Noël Keijsers, Prof.
principal investigator · Donders Institute for Brain, Cognition and Behavior, Radboud University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion